Canada Breast Cancer Diagnostics Market to be Dominated by Diagnostic & Predictive Segment Through 2028
The growing prevalence of breast cancer is expected to
drive the growth of Canada Breast Cancer Diagnostics Market in the forecast
period, 2024-2028.
According to TechSci Research report, “Canada Breast Cancer Diagnostics Market - By Region, Competition
Forecast and Opportunities, 2018-2028F,” the Canada Breast Cancer Diagnostics Market is projected to experience
significant growth in the forecast period of 2024-2028. This can be attributed
to the extensive research and development efforts, resulting in the development
of new technologies and therapies for breast cancer diagnosis across the country.
Moreover, the rising demand for advanced treatments and medications in the
medical sector has been a major driving force behind the growth of the Canadian
Breast Cancer Diagnostics Market. Additionally, the government's support and
increasing investment in new developments in medications, as well as the
improved efficiency and effectiveness of treatment, have further contributed to
the growth of the market. The availability of reimbursement and insurance
coverage is also expected to fuel the growth of the Canada Breast Cancer
Diagnostics Market during the forecast period.
However, it is important to acknowledge that breast cancer is a complex
and heterogeneous disease, and not all patients respond equally to treatment.
The development of drug resistance and treatment failure poses a significant
challenge. Cancer cells have the ability to adapt and develop resistance
mechanisms, which can reduce the effectiveness of initially successful
therapies over time, potentially impeding the growth of the Canada Breast
Cancer Diagnostics Market. In addition, the limited availability of clinical
trials and the difficulties associated with patient recruitment and retention
present obstacles to the advancement of breast cancer diagnostics. Furthermore,
as survival rates improve with advancements in treatment, it is crucial to
address the long-term survivorship and follow-up care needs of individuals.
Comprehensive survivorship programs are necessary to address long-term side
effects, disease recurrence, and the psychosocial impact of breast cancer.
These factors may pose limitations to the growth of the Canada Breast Cancer
Diagnostics Market.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "Canada Breast
Cancer Diagnostics Market.”
Canada Breast Cancer
Diagnostics Market can be segmented by type, product, application, end use, region,
and competitive landscape.
Based on Application, the Canada
Breast Cancer Diagnostics market can be segmented into Screening,
Diagnostic & Predictive, Prognostic, Research. The Diagnostic &
Predictive segment dominated the Canada Breast Cancer Diagnostics Market in 2022
and is expected to continue maintaining its dominance throughout the forecast
period. This can be ascribed to the increasing trends of genetic testing along
with advancements in this field such as the development of biomarkers, which
may support the growth of the market for breast cancer diagnostics.
Based on End Use, the market can be segmented into Hospitals & Clinics, Diagnostic Centers,
Medical Laboratories, Others. The Hospitals & Clinics segment is
expected to dominate the Canada Breast Cancer Diagnostics Market during the
forecast period on account of increasing hospitalization of patients and the
growing burden of the disease, in the country.
Major companies operating in Canada Breast Cancer
Diagnostics market are:
- Philips Canada Ltd
- Danaher Corp
- Hologic Inc
- Becton Dickinson Canada Inc
- Thermo Fisher Scientific Inc
- Genomic Health Inc
- Argon Medical Devices Inc
- Hoffmann-La Roche Ltd
Download
Free Sample Report
Customers can also request
for 10% free customization on this report.
“Canada Breast
Cancer Diagnostics is expected to dominate the market during the forecast
period on account due to the growing
prevalence of breast cancer among aging women in this region. Also, increasing
awareness about breast cancer and increasing product launches about Breast
Cancer treatments will further
propel the growth of Canada Breast Cancer Diagnostics market during the
forecast period. Furthermore, companies are focusing on strategic initiatives,
such as the introduction of novel products through customization according to
consumers’ needs, partnerships, collaborations, and mergers & acquisitions,
to expand their product portfolio and extend leadership positions in the field
of dental implantology. Besides, growing investment on cancer care is expected
to create a lucrative growth of the Canada Breast Cancer Diagnostics market
during the forecast period” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based global management consulting firm.
“Canada Breast Cancer Diagnostics Market By Type (Imaging, Biopsy, Genomic Tests, Blood Tests,
Others), By Product (Platform-based Products, Instrument-based Products), By
Application (Screening, Diagnostic & Predictive, Prognostic, Research), By
End Use (Hospitals & Clinics, Diagnostic Centers
and Medical Laboratories, Others), By Region and Competition”, has evaluated the future growth potential of Canada Breast
Cancer Diagnostics Market and provides statistics & information on market
size, structure, and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Canada Breast
Cancer Diagnostics Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com